These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9153003)

  • 1. Alterations in the turnover rate of dopamine D1 but not D2 receptors in the adult rat neostriatum after a neonatal dopamine denervation.
    Dewar KM; Paquet M; Reader TA
    Neurochem Int; 1997 Jun; 30(6):613-21. PubMed ID: 9153003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine receptor alterations correlate with increased GABA levels in adult rat neostriatum: effects of a neonatal 6-hydroxydopamine denervation.
    Molina-Holgado E; Van Gelder NM; Dewar KM; Reader TA
    Neurochem Int; 1995; 27(4-5):443-51. PubMed ID: 8845745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of D1 and D2 receptors in adult rat neostriatum after neonatal dopamine denervation: quantitative data from ligand binding, in situ hybridization and iontophoresis.
    Radja F; el Mansari M; Soghomonian JJ; Dewar KM; Ferron A; Reader TA; Descarries L
    Neuroscience; 1993 Dec; 57(3):635-48. PubMed ID: 7906013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ.
    Crawford CA; Rowlett JK; McDougall SA; Bardo MT
    Eur J Pharmacol; 1994 Feb; 252(2):225-31. PubMed ID: 8157063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.
    Thomas WS; Neal-Beliveau BS; Joyce JN
    Brain Res Dev Brain Res; 1998 Nov; 111(1):99-106. PubMed ID: 9804909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of dopamine D2 but not D1 receptors in adult rat neostriatum after neonatal 6-hydroxydopamine denervation.
    Dewar KM; Soghomonian JJ; Bruno JP; Descarries L; Reader TA
    Brain Res; 1990 Dec; 536(1-2):287-96. PubMed ID: 2150772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY; Martin-Iverson MT
    Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Neuropharmacology; 1994 May; 33(5):647-55. PubMed ID: 7936100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.
    Reader TA; Molina-Holgado E; Dewar KM
    Mol Neurobiol; 1992; 6(4):425-50. PubMed ID: 1285933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
    Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
    Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies.
    Huang N; Ase AR; Hébert C; van Gelder NM; Reader TA
    Neurochem Int; 1997 Mar; 30(3):277-90. PubMed ID: 9041559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of D1 and D2 receptor stimulation for the induction and expression of cocaine-induced behavioral sensitization in preweanling rats.
    McDougall SA; Rudberg KN; Veliz A; Dhargalkar JM; Garcia AS; Romero LC; Gonzalez AE; Mohd-Yusof A; Crawford CA
    Behav Brain Res; 2017 May; 326():226-236. PubMed ID: 28284952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of D1 and D2 dopaminergic receptor kinetics in specific rat brain regions following repeated administration of opiates.
    Elwan MA; Soliman MR
    Pharmacology; 1995 Aug; 51(2):73-83. PubMed ID: 8584575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D1 receptors are involved in the modulation of D2 receptors induced by cholecystokinin receptor subtypes in rat neostriatal membranes.
    Li XM; Hedlund PB; Agnati LF; Fuxe K
    Brain Res; 1994 Jul; 650(2):289-98. PubMed ID: 7953694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic lithium treatments on central dopaminergic receptor systems: G proteins as possible targets.
    Carli M; Anand-Srivastava MB; Molina-Holgado E; Dewar KM; Reader TA
    Neurochem Int; 1994 Jan; 24(1):13-22. PubMed ID: 8130731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lesions of mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors.
    Qin ZH; Chen JF; Weiss B
    J Neurochem; 1994 Feb; 62(2):411-20. PubMed ID: 8294904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptics and dopamine transporters.
    Reader TA; Ase AR; Huang N; Hébert C; van Gelder NM
    Neurochem Res; 1998 Jan; 23(1):73-80. PubMed ID: 9482270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors.
    Yokoyama C; Okamura H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1016-30. PubMed ID: 9023319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.